Immunome Inc (IMNM) earnings · rev $6.9M
These earnings events as JSON? API free 100/dayImmunome Inc (IMNM) is a biotechnology company listed on US.
This IMNM earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported IMNM revenue for 2025-12-31 was $6.9M. Net income was -$212.4M. Revenue was down 23.2% from 2024-12-31 to 2025-12-31. IMNM currently screens at market cap $2.47B.
When the next IMNM 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 23.2% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full IMNM research stays on the stock page; the tape stays on the quote page.
IMNM earnings FAQ
What are IMNM's latest revenue and net income?
Latest cached Immunome Inc (IMNM) revenue for Dec 31, 2025 was $6.9M. Net income was -$212.4M. Statements: https://lician.com/financials/imnm
What is IMNM's latest diluted EPS?
Latest cached Immunome Inc (IMNM) diluted EPS for Dec 31, 2025 was -$2.43.
What period does the latest IMNM earnings print cover?
The latest cached Immunome Inc (IMNM) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did IMNM revenue change from the prior cached period?
Cached Immunome Inc (IMNM) revenue was down 23.2% from $9.0M (Dec 31, 2024) to $6.9M (Dec 31, 2025). Statements: https://lician.com/financials/imnm
Where are IMNM earnings listed?
Cached earnings facts for Immunome Inc (IMNM) are listed at https://lician.com/earnings/imnm. Statements: https://lician.com/financials/imnm
Not investment advice.